Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sulfotransferase family 6B member 2, pseudogene (SULT6B2P) is a nonfunctional DNA segment that structurally resembles active sulfotransferase genes but lacks the ability to produce a functional protein due to disabling mutations. Pseudogenes like SULT6B2P are common in the human genome and do not participate in enzymatic activity, cellular signaling, or disease pathology directly. While its sequence may be useful in evolutionary or genetic studies, SULT6B2P is not a valid target for drugs, therapy, or diagnostics.
None. No mechanism of action is relevant for drugs, as it is not an active target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulfotransferase family 6B member 2, pseudogene (SULT6B2P).